2010
DOI: 10.1002/anie.200906114
|View full text |Cite
|
Sign up to set email alerts
|

Closthioamide: An Unprecedented Polythioamide Antibiotic from the Strictly Anaerobic Bacterium Clostridium cellulolyticum

Abstract: Choose sulfur in an oxygen‐free world: Closthioamide (1) was isolated from the anaerobe Clostridium cellulolyticum (see SEM image) after the induction of its biosynthesis with an aqueous soil extract. An unprecedented type of symmetrical natural product in which all building blocks are connected through thioamide linkages, 1 is active against multiresistant staphylococci. It is the only known secondary metabolite from a strictly anaerobic bacterium.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
62
0

Year Published

2012
2012
2023
2023

Publication Types

Select...
6
2

Relationship

2
6

Authors

Journals

citations
Cited by 182 publications
(63 citation statements)
references
References 24 publications
1
62
0
Order By: Relevance
“…For instance, Clostridium cellulolyticum produces a copper-binding secondary metabolite, closthioamide, with a molecular mass similar to that of mbs (158)(159)(160), and like mbs, closthioamide has thioamide groups, will reduce Cu 2ϩ to Cu 1ϩ , and has a high Cu 1ϩ binding affinity (Ͼ10 15 M Ϫ1 ). Closthioamine will also test positive with the copper-chrome azural S (Cu-CAS) assay, a liquid or plate assay used to screen for mb production (138,149,161).…”
Section: Methanobactins As Chalkophoresmentioning
confidence: 99%
See 1 more Smart Citation
“…For instance, Clostridium cellulolyticum produces a copper-binding secondary metabolite, closthioamide, with a molecular mass similar to that of mbs (158)(159)(160), and like mbs, closthioamide has thioamide groups, will reduce Cu 2ϩ to Cu 1ϩ , and has a high Cu 1ϩ binding affinity (Ͼ10 15 M Ϫ1 ). Closthioamine will also test positive with the copper-chrome azural S (Cu-CAS) assay, a liquid or plate assay used to screen for mb production (138,149,161).…”
Section: Methanobactins As Chalkophoresmentioning
confidence: 99%
“…Pyrazinedione rings are even more uncommon and have been detected only in the non-amino-acidcontaining molecules selerominol (167) and flutamide (168) from fungi. The presence of thioamide groups in natural products is also rare and has been identified only in closthioamide from Clostridium cellulolyticum (153,160) and thioviridamide from Streptomyces olivoviridis (169,170). Although rare, O-sulfonation of Ser or Thr has been reported in eukaryotic proteins (171), but to our knowledge, mb is the only bacterial peptide that contains this posttranslational modification and is ribosomally produced, as described below.…”
Section: Structural Properties Of Methanobactins Structural Diversitymentioning
confidence: 99%
“…In an attempt to harness the biosynthetic potential of Clostridium cellulolyticum cultures were subjected to >30 stress conditions including heat shock, heavy metal and antibiotic stress (Fig. 4) (Lincke et al, 2010). Yet only upon the addition of an aqueous soil extract to C. cellulolyticum cultures a new compound, named closthioamide, was detected (Lincke et al, 2010).…”
Section: Anaerobes -An Overlooked Source Of Novel Compoundsmentioning
confidence: 99%
“…4) (Lincke et al, 2010). Yet only upon the addition of an aqueous soil extract to C. cellulolyticum cultures a new compound, named closthioamide, was detected (Lincke et al, 2010). Closthioamide has an unusual symmetric structure and is very rich in thioamide moieties, which are rarely found in nature.…”
Section: Anaerobes -An Overlooked Source Of Novel Compoundsmentioning
confidence: 99%
“…Yet, not a single gene cluster could be linked to a metabolite. In C. cellulolyticum, a group of unusual new polythioamide metabolites, the closthioamides (1-8), has already been identified (Behnken et al 2012;Lincke et al 2010), and their biosynthetic pathway is now under investigation. The high antibiotic activity and structural novelty of closthioamide (1) suggests that more unique drug leads can be unearthed from anaerobes-thus complementing the biosynthetic potential of established aerobic antibiotic producers.…”
Section: Discussionmentioning
confidence: 99%